Conference Update: Mobile Healthcare Communications

Posted in BioEducation

 

  

Date:Thursday, January 26, 2012
Time: 8:00 a.m. – 1:00 p.m.
Place:The Graduate Center of The City University of NY; 365 5th Ave; NY, NY 10016 
Registration Fee: $195.00
Website: http://www.bdionline.com/mobilehealthcare2012.html

Mobile Healthcare Communications News
Five Reasons Why Physicians Need to Use Social Media, 12/12/11 HealthWorks Collective
Hospital sends heart failure patients home with smartphones.
12/15/11 Fierce Mobile Healthcare
Educate your hospital staff to protect against text-related mistakes,
12/19/11 Fierce Mobile Healthcare 

About the Event:
Consumers and professionals are increasingly using their mobile devices for healthcare information. They are also interacting with healthcare providers and colleagues on their mobile phones. This conference will demonstrate the best case studies of how major healthcare brands are connecting with consumers and professionals through mobile communications. 

Speakers and Roundtable Moderators:
Meighan Berberich, Vice President, Marketing, BlogTalkRadio
Lance Hill, CEO, Within3
Scott Hopkins, Executive Vice President, Anderson Direct Marketing
Monique Levy, Senior Director, Research, Manhattan Research
Dr. Katherine Malbon, Assistant Professor of Pediatrics, Division of Adolescent Medicine, Mount Sinai Hospital
Talya Miron-Shatz, PhD, Marketing Department, Wharton, University of Pennsylvania
Jenna Mons, Consumer Product Manager for LAP-BAND®, Allergan 
Mario Nacinovich, Jr., Editor-in-Chief, Journal of Communication in Healthcare; Managing Director, AXON
Xavier Petit, Shire 
John Vieira,Daiichi-Sankyo

Hotel Sponsor:Hotel 373 is the official hotel of BDI’s events.Click here to receive a discounted rate.

Sponsors:
PR NewswireWithin3Anderson Direct MarketingBioCrowd ; CinchcastJournal of Communication in HealthcareManhattan ResearchNew York UniversityPixels and PillsPublic Relations Society of America – New York ChapterSociety for Healthcare Strategy and Market Development

For event related questions and registration, please contact Maria Feola-Magro at mfeola@bdionline.com or 212.765.8043.
For sponsorship/speaking opportunities, including pricing, please click here or contact Jennifer Brous at jbrous@bdionline.com or 212-765-8358.

For additional information, including registration, please click here to visit the event website. Use promo code BC for a discounted rate of $175.

 

 

Mobile Healthcare Communications Conference for 2012

Posted in Social Media

Increasingly, healthcare professionals, patients and consumers are turning to and using their mobile devices for healthcare information. Further, development of mobile software platforms and associated are allowing patients to more regularly directly communicate with their physicians. To help sort out the growing complexity of the mobile healthcare communications industry, the Business Development Institute (BDI) entitled “Mobile Healthcare Communications 2012:Case Studies and Roundtables” will be held on Thursday, January 26, 2012 from 8:00 AM to 1:00 PM at The Graduate Center of the City University of NY (365 5th Ave, NY, NY 10016).

Registration fee for the event is $195 per attendee. BioJobBlog readers who wish to attend should use promo code BC for a discounted rate of $175.

Speakers and roundtable moderators include:

  1. Lance Hill, CEO, Within3
  2. Scott Hopkins, Executive Vice President, Anderson Direct Marketing
  3. Dr. Katherine Malbon, Assistant Professor of Pediatrics, Division of Adolescent Medicine, Mount Sinai Hospital
  4. Talya Miron-Shatz, PhD, Marketing Department, Wharton, University of Pennsylvania 
  5. Jenna Mons, Consumer Product Manager for LAP-BAND®, Allergan 
  6. John Vieira, Daiichi-Sankyo

Event sponsors include:

BioCrowd, PR NewswireWithin3 ; Anderson Direct MarketingCinchcastJournal of Communication in HealthcareManhattan ResearchNew York UniversitySociety for Healthcare Strategy and Market DevelopmentPixels & Pills

For event related questions and registration, please contact Maria Feola-Magro at mfeola@bdionline.com or 212.765.8043.

For sponsorship/speaking opportunities, including pricing, please click here or contact Jennifer Brous at jbrous@bdionline.com or 212-765-8358.

For additional information, including registration, please click here to visit the event website.

See you at the conference!

Until next time….

Good Luck and Good Job Hunting!!!!!!!

Maximizing Patient Engagement During Clinical Trials

Posted in BioBusiness

Recruiting, retaining and managing patients that participate in clinical trials for approval of new medicines and devices have becoming very challenging in the past decade or more. Ironically, the ready availability of experimental new medicines in the US for certain therapeutic areas including oncology, neuroscience and vaccines have forced life sciences companies and CROs to conduct many Phase I and Phase II trials outside of the US. In turn, the globalization of clinical trials has forced many sponsors to increasingly rely on e-based and mobile solutions for patient recruitment, retention and compliance.

The Advance Learning Institute’s conference entitled “Patient Recruitment, Compliance And Retention For Clinical Trials: Integrating The Latest Technologies With Traditional Tools To Maximize Patient Engagement” that will be held in Manhattan on October 24-26, 2011 will provide attendees with insights into the best practices to maximize patient engaged in clinical trials. Presentations will be given by a variety of pharmaceutical companies, CROs and academic institutions including Pfizer, Merck Research Laboratories, Shire Pharmaceuticals, Celgene Corporation, Quintiles, Omniscience Mobile, Albert Einstein College of Medicine and the Michael J. Fox Foundation for Parkinson’s Research. A complete agenda for the conference can be found here.

Those of you who mention BioJobBlog or BioCrowd when registering for the conference will receive a $200 registration discount.

See you at the meeting!!!!!!!

Until next time…

Good Luck and Good Job Hunting!!!!!!!

 

Social Media Update: US Food and Drug Administration To Regulate Mobile Apps?

Posted in Social Media

Mark Senak, author of the highly informative and well written Eye on FDA blog, reported today that a recent article that appeared on the American Medical News website suggests that the US Food and Drug Administration (FDA) may be considering regulating mobile apps that contain medical or clinical components. While the agency has yet to officially publish guidance on the use of social media in the life sciences industry, it now appears that FDA may be turning its attention on the development of mobile apps; one of the fastest growing segments of the social media movement.

The reason why FDA is taking notice of mobile apps is because a handful of app developers have sought and received FDA clearance for their mobile apps that—because of clinical components —are considered to be “medical devices.” As many of you may know, medical devices which include band-aids, surgical instruments, heart monitors, cardiovascular stents and diagnostic kits, all must receive marketing approval by the agency before they can be sold in the US. Although the agency yet to craft any guidance for clinical/medical app development, it makes sense that FDA ought to evaluate and regulate these products to insure that they are medically-effective and safe. 

According to the American Medical News article, the first app developer to receive FDA market clearance was AirStrip Technologies in San Antonio, for its AirStrip OB application. The app, which was approved in 2009, allows physicians to monitor mother and newborn remotely during delivery. In February, the FDA granted clearance to MobiUS, an app developed by Mobisante, a medical device company in Redmond, Wash. The app permits viewing of medical images for diagnostic purposes. Mobile MIM, a remote diagnostic imaging tool developed by Cleveland-based MIM Software, was also granted market clearance that month. A number of pharmaceutical companies, most notably Pfizer, have been extremely active in the mobile clinical app development space.

The reason why it makes sense for FDA to regulate certain clinical/medical apps is because physicians will rely on them to make medical decisions. For example, the AirStrip OB mentioned above will ostensibly allow physicians to remotely monitor a mother and neonate during delivery. Consequently, the app, aka device, must be evaluated by the agency to determine whether or not it can be used safely and effectively by physicians during childbirth. In this case, the app is similar to a heart monitor that is used during childbirth. And, like all other medical devices, the heart monitor required FDA clearance to determine its safety and effectiveness, before it could be used in real-life childbirth situations. To that end, the agency has hinted that it will be much more proactive in monitoring this new class of devices.

I have no doubt that many pharmaceutical companies and medical devices manufacturers will not be pleased when they learn that the agency is going to “stick its nose” into mobile app development. Nevertheless, in my opinion, if a mobile app is going to be used in possible “life or death” situation, then it ought to be regulated by FDA—the agency that is legally responsible for regulating these types of products. That said, Eye on FDA’s Mark Senak raises a number of valid and insightful points about FDA and its possible role in mobile app development.

“Related to a possible guidance for apps, there are a lot of questions that need to be answered when considering its development – when is an app a medical app?  When does it require regulation?  Who will pay for the oversight – will there be App Developers User Fee Act (ADUFA?) and if so, what will that do to the price and to access.  Will insurance companies have to cover apps?  And what will the process for approval be – something like a 510(k)?”

Finally, I think that the app developers who proactively approached FDA for guidance abut the clinical apps that they were developing “got it right.” This will get the agency “thinking” about clinical/mobile apps and how they ought to be approved and regulated in the future. In turn, this will provide future app developers with a clear regulatory framework that will guide the development of cost effective, safe and efficacious mobile clinical apps.

Until next time…

Good Luck and Good Job Hunting!!!!!!!

 

Pharmaceutical Direct-to-Consumer (DTC) Advertising Goes Mobile

Posted in BioBusiness

While big pharma continues to struggle with the use of social media to promote its products, direct-to-consumer advertising (DTC), the method of choice for American pharmaceutical advertising is alive, well and robust. Therefore, it should come as no surprise that big pharma is reallocating some its traditional DTC advertising dollars to deliver drug ads to mobile devices which are growing in popularity. 

According to a recent article posted on PharmaLive, drug companies are mainly using mobile devices —in addition to delivering ads—to “help educate patients and motivate them to seek, accept, and adhere to therapy.” In other words, to more effectively promote their products to improve sales and corporate profits. Regardless of the motive, medical communication agencies have recognized the trend and have responded by launching mobile divisions and initiatives at their firms. Some agencies are now generating close to 50% of their revenues from mobile initiatives and campaigns. Further, many pharmaceutical companies have finally realized that corporate websites can be more than simple placeholders on the Internet. To that end, the PharmaLive post notes that pharmaceutical brand websites are evolving into a robust resource structured to be easily searchable and maintained. Maybe a better understanding and use of social media is next up for drug makers.

Pfizer remains the leading spender and purveyor of DTC advertising despite a 15% overall decrease in 2010 as compared with 2009. PharmLive reports that the company allocated $903.8 million to brands such as Lipitor, Pristiq, Viagra, Chantix, and Lyrica. Of these brands, Pristiq saw the highest increase of DTC advertising in 2010, up 17% to $122.2 million compared to 2009.

As mobile media continues to grow, don’t be surprised if someone develops a TIVO-like fast forward app to skip all of the DTC ads on your iPhone or android devices.

Until next time..

Good Luck and Good Job Hunting!!!!!

 

Using Social Media Tools to Improve Information Flow At Scientific and Medical Meetings

Posted in Social Media

Science and medical conference season is in full swing and tens of thousands of persons are attending scientific and medical meeting all over the US. While social media is no longer a new “thing” only a few scientific and medical societies understand its power and ways in which it may be harnessed to improve the experiences of their members who attend their national meetings. 

At most of the scientific conferences that I attend (usually four to fiver per year), people still lug around and are tethered to printed program guides. Further there is no easily accessible electronic repository (aside from the conference website) or guide that conference attendees can use to optimize time management and see “everything” that they want to at the meeting. Unfortunately, most scientific and medical conferences are still being run the same way that they have been for the past 30 years despite improvements to internet access and bandwidth, the advent of social media and the recent explosion of mobile devices and apps.

Finally, and perhaps most egregiously, rather than publicly disseminating what is being reported at these meetings, conference attendees and the lay public must rely on carefully orchestrated press releases (chosen in advance by the organizing committees of the meetings) for information and late-breaking news from the events. This is so web 1.0 that it is almost laughable.

Until last week, I thought that I was the only person who felt this way about social media and medical and scientific congresses. Imagine my surprise when no fewer than three others social media enthusiasts including Mark Senak, author of the EyeonFDA blog, Brian Reid, author of the WCG Common Sense Blog and Sally Church, author of the Pharma Strategy Blog, last week authored posts on the topic! It is always refreshing to find like-minded individuals to confirm that you are not alone!

Unfortunately, many scientific and medical societies like to tightly control information flow, limit access to it and, not surprisingly, are quite suspicious of social media. This is because the use of social media decreases the ability of these societies and their journals to control their messaging and content dissemination. With this in mind, is it any wonder why American scientific and medical literacy is pretty much in the “toilet?”  While the lay public may not be able to understand peer-reviewed scientific and medical publications, they have grown accustomed to gathering information on Facebook, Twitter and most importantly blogs. Why not use these vehicles to better inform the public about scientific or medical breakthroughs that have been validated and generally regarded as authentic?

Like it or not, social media is here to stay. And if leveraged correctly, it can be an extremely effective educational tool. I think that it is time for scientific and medical societies to consider using social media at their annual meetings. A failure to do so may have negative consequences for future membership in these societies and also reduce their effectiveness as purveyors of timely and accurate scientific and medical information!

Until next time…

Good Luck and Good Job Hunting!!!!!!!!!!!

 

Reports of E-Mail Demise May be Greatly Exaggerated

Posted in Social Media

ComScore, a company that tracks Internet traffic recently determined that the number of visitors to Web-based e-mail sites, like Gmail, Yahoo mail and others, declined roughly 5.9 per cent from November 2009 to November 2010. In November, 2009 160 million users used web-based e-mail platforms whereas only 153 million used those services. 

According to comScore, the decline represents the growing use of mobile e-mail devices like Blackberry and the iPhone which don’t require their users to log on to the Web to view messages. However, while the number of people who use mobile devices to check e-mail daily rose to 40 per cent, it isn’t clear whether or not the conclusions drawn by comScore are accurate. For example, I use Yahoo mail daily to check e-mail messages on my iPhone. Moreover, although Web-based e-mail use by persons aged 12 to 17 years dropped 24 percent over the past year, the number of users aged 55 years and older continues to rise. Finally, while my children aged 17, 15 and 12 prefer text and chat to e-mail they all still use web-based e-mail for formal communications with their teachers and older persons. I suspect that this is not very surprising to many BioJobBlog readers because the number of baby boomers (old fogies who are comfortable with e-mail) will continue to overshadow the number of Gen X and Gen Y persons for many years to come. Put simply, we boomers are still in control and will not relinquish it until we all die! And, once, we are gone, things are likely to change.

The point that I am trying to make is that while texting, Twitter and Facebook may be appropriate for informal communication among tweens, teenagers and young adults, e-mail is, and will continue to be, the major means of communication for business purposes. This is mainly because e-mail is much easier to monitor, capture, manage and oversee than texting, Twitter or Facebook. And, perhaps more importantly, unlike the previously mentioned “new” forms of communication, archived e-mail messages are now routinely used in American courts to adjudicate legal disputes that arise between individuals and companies. In other words, e-mail messages are now recognized as being part of the “official record” for legal and business purposes.

Coincidentally, on a college visit last week to a small liberal arts college, our undergraduate guide—a 20-something undergraduate communications and marketing major—quietly shared with me that she doesn’t get the whole Twitter, Facebook and texting “thing.” She said she regularly communicates with college administrators, her professors and most of her classmates via e-mail; mainly because the other forms of communication require immediate attention. And, if you are busy or have work to do or don’t want to talk to someone that can be troublesome. As far as she was concerned, e-mail was the best way to communicate. I am not sure whether or not she said what she did about e-mail for my sake, because during our conversation, she paused for a moment to read a text message from her friend admonishing her that she was late for a lunch date.

Until next time…

Good Luck and Good Job Hunting.

 

Mobile HealthCare Applications Represent the Next Frontier in the Life Sciences Industry

Posted in Social Media

While the debate rages on over the use of social media in the life sciences industry, industry experts and insiders have largely ignored the growing importance of mobile healthcare and its use by healthcare professionals and patients. Consumers and professionals are increasingly using their mobile devices for healthcare information. They are also interacting with healthcare providers and colleagues on their mobile phones. 85% of US consumers have cell phones and growing vs. only 65% of Americans which have broadband access. Further, the divide between mobile use and broadband Internet access is increasing. According to a Manhattan Research report 70% of Physicians say PDAs/Smartphones are "essential" to their practice.

Because of the growing importance of mobile healthcare communications, the Manhattan-based Business Development Institute decided to organize a conference around this theme. The primary goal of the conference is to address the following questions:

  1. How do healthcare brands connect and interact with consumers via mobile strategies?
  2. How do healthcare brands connect and interact with healthcare professionals via mobile strategies?
  3. What are the leading technologies being used for mobile strategies?
  4. How do you deal with regulatory hurdles when implementing mobile campaigns?
  5. How do you integrate your mobile strategies into your enterprise-wide marketing, communications and social media platforms?
  6. What are the leading monitoring and measuring approaches/technologies being employed for mobile campaigns?

Person giving presentations at the meeting include:

Lance Hill, CEO, Within3
Ray Kerins, Vice President/Worldwide Communications, Pfizer Inc.
Marc Monseau, Director, Corporate Communications and Social Media, Johnson & Johnson
Todd Siesky, Public Relations Manager, Roche Diabetes Care
 
Date: Wednesday, January 19, 2011
Time: 8:00 a.m. – 1:00 p.m.
Location: The Graduate Center of The City University of NY; 365 Fifth Avenue; New York, New York 10016
Registration Fee: $195
Website:http://www.bdionline.com/mobilehealthcare.html

For more information, including registration, please click here to visit the event website. Use promo code BC for a discounted rate of $155.

Please contact Steve Etzler at setzler@bdionline.com or 212-765-8045 for additional information.

See you at the meeting!

Until next time…

Good Luck and Good Job Hunting!!!!!

 

Mobile Apps for Life Sciences Researchers

Posted in BioJobBuzz

There is no question that mobile apps are de rigueur and like other mobile devices users, life science researchers are beginning to regularly use them! After all, any innovation that can make the long hours spent doing laboratory research, easier, less time-consuming and enjoyable are likely to be welcomed by most researchers.

According to Alex Hodgson, one of the founders of the antibody review site called BioHub Online “mobile apps for science-types are popping up everywhere.” These apps range from lab timers, to mobile notebooks and science journals. 

Alex recently reviewed several mobile science apps on the BioHub Blog  that “piqued her interest” Some of the apps may be familiar to you while others may not. This is what she had to say:

‘Bio-Apps: Technology Meets Science’

By Alex Hodgson

Mendeley iPhone App
Free

This application indexes and organizes all of your PDF documents and research papers into your own personal digital library. It gathers document details from your PDFs allowing you to search, organize and cite. It also looks up PubMed, CrossRef, DOIs and other related document details automatically, importing papers quickly and easily from resources such as Google Scholar, ACM, IEEE and many more at the click of a button. 

Sync with Mendeley
Mendeley (Lite) for iPhone syncs seamlessly with your Mendeley research collection. This means that you can now carry your personal digital library with you wherever you go. 

Read your Papers Offline
If there is a paper you want to check out later, you can download it over wifi straight to your iPhone from your online library. It will remain available to read offline at any time, making it easy for you to read what you want, when you want.

Share Citations
If there is a paper that you just need to let your colleagues know about right now, you can share the citation to that paper from within the app via email.

Molecules
Free

Molecules is an application for the iPhone, iPod touch, and now iPad that allows you toview three-dimensional renderings of molecules and manipulate them using your fingers. You can rotate the molecules by moving your finger across the display, zoom in or out by using two-finger pinch gestures, or pan the molecule by moving two fingers across the screen at once. The combination of the iPhone, iPod touch, and iPad’s unique multitouch input system and the built-in OpenGL ES 3D graphics capabilities enable you to feel like you are manipulating the molecules themselves with your fingers.

New molecules can be downloaded from the RCSB Protein Data Bank

Primer Jot
$0.99

This molecular biology application aims to help you keep track of your oligos, all in one place, calculate the primer melting temperature (Tm) (based on a standard set of conditions) and categorize it, assign a project, as well as physical location details. Search feature ever allows you to quickly search primers/oligos based on name, project, sequence, Tm and even your notes. A must-have for anyone who works with PCR.

BioLegend Tools for the iPad/iPhone Application
All Free

BioLegend CD Molecules Applications
The application compiles information on all of the Human and Mouse CD Markers based on the findings of the HLDA workshop. Now you can find CD molecule information quickly and conveniently in the palm of your hand.

Cytokines & Chemokines Application
This application provides you with important information about your mouse and human cytokines and chemokines. Now you can find information about cytokines and chemokines quickly and conveniently in the palm of your hand.

BioLegend Tools for the iPad
This application includes information on Human & Mouse CD Molecules from the HLDA Workshop and Cytokines & Chemokines,an Antibody Usage Calculator as well as a lab timer.

Apps from Invitrogen
Free

DailyCalc
Calculate molarity and formula weight, or find unit conversions and cell culture references all with this smart calculator widget.

Alexa Fluor Selection Guide
This handy app serves as a quick reference guide for selecting the perfect Alexa Fluor® dye for your research.

Promega
Free

This application provides lots of great information for life scientists, including quick access to molecular biology calculators, technical tips, protocols, and multimedia presentations. The calculators provide a range of functions essential to molecular biology experiments, including DNA and protein conversions, melting temperature, molarity and dilution calculations.

The Protocols & Applications section of the App covers molecular, cell biology, DNA and protein analysis procedures, and is divided into chapters covering a comprehensive range of topics –from basic amplification techniques to real-time PCR, from simple cell-based assays to complex imaging techniques, and from protein expression to more involved protein interactions assays.

All are available through iTunes

Until next time…

Good Luck and Good Researching!!!!!!!!!!

 

Social Media, Clinical Trial Recruitment and Mobile Healthcare Apps

Posted in Social Media

About a year ago I posted an article to BioJobBlog that suggested that social media can be leveraged to improve clinical trial recruitment to test investigational new drug candidates. Yesterday, Mark Senak, author of the EyeonFDA posted an article which suggested that the use of video on YouTube and other video-viewing sites makes complete sense to recruit prospective participants for human clinical trials. Here are some of Mark’s thoughts on the topic:

“The reasons I think video is a good way to expose people to learning about clinical trials are multiple. First, it allows me as a prospective clinical trial participant to learn about a clinical trial when I want to learn about it and where I want to learn about it – a hallmark of social media.  Second, it is private – I can learn from a video that can be developed to address a wide range of issues – issues that I might not be so comfortable addressing with a live person.  Thirdly, and perhaps most importantly, I learn about the clinical trials perhaps from someone on a video who is very much like me.  He can be someone with my condition – someone who has gone through a trial, and talk about how his concerns were addressed, what his fears were and what the benefits of participation were.  That, I think, is a much more convincing way to learn about a trial than an ad in a newspaper or even a discussion with a clinical person.  Video can’t replace the medical professional, but it sure can get my interest and perhaps trust to make recruitment much easier.”

While the industry’s use of social media for this purpose is not quite there yet, there are some signs that pharmaceutical and biotechnology companies may be trending in that direction. First, a growing number of clinical research organizations (CROs) which help companies plan and manage clinical studies are already using social media tools to recruit prospective clinical trials participants. Second, as Mark reported yesterday, Pfizer launched a YouTube channel called PfizerClinicalTeam last July which presumably would bolster clinical trial recruitment. Unfortunately, as Mark pointed, its most recent video was posted in April, 2010, regarding a new study on schizophrenia. Don’t be surprised if other companies launch social media-focused clinical trials recruitment campaigns in the not too distant future. Like Mark, I believe that social media tools are ideal for this purpose!

In other news, Pfizer, a late entrant to the fledgling pharmaceutical social media space, is showing signs that it is beginning to embrace the social media web. Yesterday, Pfizer and Epocrates announced a collaboration to create an application for the iPhone that gives healthcare providers mobile access to the Pfizer Medical Information Group to obtain medical and science information about Pfizer products or to report adverse events. According to Pfizer, it is creating the app to: “enable easy, direct access to its Medical Information services, via the Epocrates channel, in an effort to enhance the safe and effective use of its medicines, and help improve the quality of patient care.”

Direct access to medical information via mobile devices is growing in popularity among physicians and other healthcare providers because it enables them to get answers on the go without wasting time to fire up a laptop or find a tethered computer to use outside of the clinic.

Despite assertions to the contrary by most pharmaceutical and biotechnology companies, social media tools are ideal vehicles for adverse event reporting and post market drug surveillance activities. Pfizer’s creation of a mobile medical information app coupled with the launch last week of a joint US Food and Drug Administration (FDA) and National Institutes of Health drug safety portal called Safety Reporting Portal (original eh?) suggest that the use of social media tools for online adverse event reporting and drug safety purposes is not too far off. Let’s see what develops over the next year or so after FDA issues regulatory guidance on the use of social media in the life sciences industry.

Until next time…

Good Luck and Good Job Hunting!!!!!!!!!